22 Series A Biotech investors
As of October 16, 2026, DryPowder lists 22 Series A Biotech venture funds. Their median published check range is $250K–$2.5M (7 of 22 funds publish one). 1 has filed an SEC Form D in the last 90 days: Serra Capital (Oct 7, 2026).
Free fund match
Which Series A Biotech funds are writing checks right now?
About 30 seconds. No signup or card needed. Ranked by thesis fit and check size.
- funds listed
- 22
- median check (7 of 22 publish one)
- $250K–$2.5M
- filed an SEC Form D in the last 90 days
- 1
- last updated, 2026
- Oct 16
Filed a Form D in the last 90 days
- Serra CapitalChampaign$25M offeringFORM D
All 22 Series A Biotech funds
- True VenturesSan Francisco$250K–$2MSeedSeries A
Accelerating AI-native founders at the earliest stages. Lead early rounds in companies and founders building the future, providing that first check…
4 partners listed - $2M–$3MSeries A
Partner with visionary founders to build iconic B2B software companies. Early stage venture firm managed by former founders and operators investing…
9 partners listed - NFXSan Francisco$250K–$2MSeedSeries A
NFX identifies and backs founders building companies with network effects. The fund emphasizes software development, founder support through…
6 partners listed - BoxGroupNew York$250K–$2.5MSeedSeries A
Investing in dreams at the earliest stage, backing founders across marketplaces, fintech, developer tools, frontier tech, climate, and experimental…
Partners not yet listed - Pillar VCSan Francisco$500K–$5MSeedSeries A
Partner at inception with technically brilliant founders who see past impossible to inevitable. Invest in technical breakthroughs becoming…
Partners not yet listed - Capital FactoryAustin$25K–$2MSeedSeries A
Back the most ambitious founders in Texas advancing civilization through deep tech across space, energy, bio, and AI — with cash, customers, and the…
Partners not yet listed - $250K–$3MSeedSeries ASeries BGrowth
Speedinvest provides European startups with 'more expertise, connections, reach, and momentum' through specialist investment teams across six core…
Partners not yet listed - Serra CapitalChampaign
Catalyzing innovation through early-stage tech startup funding across the United States, with over 100 companies funded to date.
4 partners listed - AgFunderSan FranciscoSeedSeries ASeries B
Investing in deeptech and foundational technologies that remove structural constraints to sustainable scale in food, agriculture, and planetary…
Partners not yet listed - AME Cloud VenturesPalo AltoSeedSeries ASeries B
Investing in entrepreneurs building infrastructure and value chains around data, from the full data stack (infrastructure to applications) with…
Partners not yet listed - Correlation VenturesSan FranciscoSeedSeries ASeries B
Correlation Ventures backs groundbreaking technology and data science companies that solve industry problems through rapid decision-making and…
Partners not yet listed - CincyTechCincinnatiSeedSeries A
Invest in innovative founders tackling the world's complex challenges, partnering early to help transform ideas into world-class companies.
Partners not yet listed - Golden VenturesTorontoSeedSeries ASeries B
Founder-driven investing focused on bold teams and transformative ideas. Hands-on approach informed by past lives as founders and operators.
Partners not yet listed - Dentsu VenturesTokyoSeedSeries ASeries BSeries CGrowth
Support domestic and international startups through capital provision and business collaboration, leveraging Dentsu Group's creative and strategic…
Partners not yet listed - SeedSeries ASeries B
Early-stage venture firm investing in technical founders solving hard engineering and science problems through the 'Super Evolution' — a non-linear…
Partners not yet listed - SeedSeries ASeries BSeries CGrowth
Multi-stage venture capital firm that goes beyond traditional VC playbook by providing entrepreneurs support of a global ecosystem, connecting…
Partners not yet listed - SeedSeries A
Building breakthrough biotechs through partnerships with world-class life science entrepreneurs, translating groundbreaking science into…
Partners not yet listed - SeedSeries ASeries B
Early-stage tech investments in the US and Israel, providing access and meaningful connections to help brilliant minds breakthrough.
Partners not yet listed - SeedSeries A
Back founders on a mission to industrialize scientific and technological progress.
Partners not yet listed - Level VenturesNew YorkSeedSeries A
Capital partner to outlier managers and entrepreneurs, building systems for speed, clarity, and conviction in investment decisions.
Partners not yet listed - Pentech VenturesLondonSeedSeries ASeries B
Supporting ambitious founders to build category defining companies
Partners not yet listed - SeedSeries ASeries BSeries CGrowthPartners not yet listed
How this list is built
DryPowder lists every fund with a public profile tagged Series A and Biotech. Funds whose largest published check is $5M or less come first; inside each group, funds with a verified SEC Form D in the last 30 days lead, then profile quality decides. Form D dates come from SEC EDGAR, and SPV and single-deal filings are dropped. Check sizes are what each fund publishes; the median uses only the 7 funds that publish one.
Related investor lists
Other cities
Biotech at other stages
Series A investors by sector
Hubs
How DryPowder compares
Frequently asked questions
How many Series A Biotech VCs are there?
As of October 16, 2026, DryPowder lists 22 Series A Biotech venture funds with a public profile. The first 5 on this page are True Ventures, Lewis and Clark Ventures, NFX, BoxGroup and Pillar VC.
Which Series A Biotech VCs are actively investing right now?
1 of the 22 filed a verified SEC Form D in the last 90 days, a sign of a new fund being raised: Serra Capital (Oct 7, 2026). Each filing links to its record on SEC EDGAR.
What check size do Series A Biotech VCs write?
The median published range is $250K–$2.5M, across the 7 of 22 funds that publish a check size. Published checks on this list run from $25K to $5M.
Where are Series A Biotech VCs based?
Of the 22 Series A Biotech venture funds, 5 are in San Francisco, 2 are in New York, 1 is in London and 1 is in Palo Alto. The rest are elsewhere or have no headquarters city on file.
How does DryPowder build this list?
A fund is listed when its public profile is tagged Series A and Biotech. Funds whose largest published check is $5M or less come first; within each group, funds that filed a Form D in the last 30 days lead, then profile quality decides. Form D dates come from SEC EDGAR, with SPVs excluded. Data as of October 16, 2026.
Sources
- SEC EDGAR: Form D, Serra Capital ($25M offering), filed
- Website: True Ventures website
- Website: Lewis and Clark Ventures website
- Website: NFX website
- Website: BoxGroup website
- Website: Pillar VC website
- Website: Capital Factory website
- Website: Speedinvest website
- Website: Serra Capital website
- Method: How DryPowder builds its data
Updated